Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-22-027648

Chief Executive Officer sold 5,675 shares at $215.63 ($1,223,727)

  • Chief Executive Officer acquired 5,675 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Farrell Michael J. · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-12-15 Exercise or conversion : show line 1 in the form +5,675 $57.76 $327,788 442,575 D
2022-12-15 Sale : show line 2 in the form −5,675 $215.63 $1,223,727 436,900 D
Open-market sales · 5,675 sh · avg $215.63 · $1,223,727

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-12-15 Exercise or conversion : show line 3 in the form ResMed Common Stock Options −5,675 65,890 D
Loading xslF345X03/form4.xml…